Physician Wealth Advisors’s Edwards Lifesciences EW Stock Holding History

Physician Wealth Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.5K	Buy	205 +61	+42%	+$5.11K	﹤0.01%	688
2026 Q1	$11.5K	Sell	144 -24	-14%	-$1.98K	﹤0.01%	761
2025 Q4	$14.3K	Buy	168 +94	+127%	+$7.71K	﹤0.01%	667
2025 Q3	$5.75K	Buy	74 +24	+48%	+$1.88K	﹤0.01%	885
2025 Q2	$3.91K	Buy	50 +26	+108%	+$1.94K	﹤0.01%	861
2025 Q1	$1.74K	Buy	+24	New	+$1.72K	﹤0.01%	900

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Physician Wealth Advisors's EW Position: Q2 2026 in Review

Physician Wealth Advisors increased its Edwards Lifesciences (EW) stake by 42% in Q2 2026, buying an estimated $5.11K and bringing the position to 205 shares worth $18.5K. The position accounts for ﹤0.01% of the portfolio, ranked #688.

Physician Wealth Advisors first reported a position in EW in Q1 2025 and has held it in 6 quarters since. 314 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Physician Wealth Advisors held 205 shares of Edwards Lifesciences worth $18.5K as of Q2 2026.
Physician Wealth Advisors bought 61 Edwards Lifesciences shares in Q2 2026, an estimated $5.11K.
Edwards Lifesciences made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #688 holding.
Physician Wealth Advisors first reported a position in Edwards Lifesciences in Q1 2025 and has held it in 6 quarters since.
314 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.